Aiforia deal to expand access to pathology AI

pharmafile | October 22, 2026 | News story | |  AI, Corporate, Devices, Hospital Management, commercial agreements, digital pathology 

Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to laboratories through PathAI’s AISight Marketplace.

The agreement will extend the reach of Aiforia’s AI models to laboratories using AISight Dx, PathAI’s image management system, with a particular focus on expanding Aiforia’s presence in the US market. Aiforia’s solutions include CE-IVD-marked software for digital pathology in Europe.

The companies said the integration would make Aiforia’s models available within existing pathology case-review workflows. PathAI’s platform also connects laboratories with laboratory and hospital IT systems and offers algorithms for biomarker quantification, tissue classification and diagnostic decision support.

Advertisement

Jukka Tapaninen, Chief Executive Officer of Aiforia, said the agreement would help the company reach laboratories and pathologists already using PathAI’s platform.

Nick Brown, Chief Growth Officer at PathAI, said the aim was to give pathologists access to a broader set of tools within a single system.

The agreement expands the commercial distribution of Aiforia’s software, although the announcement does not specify the number of laboratories expected to gain access or the anticipated financial contribution.

NEWS: On a separate note, Aiforia has won Finland’s Digital Innovation of the Year 2026 public vote in the enterprise category for its AI-based cancer diagnostic software.

Related Content

AI: an early warning system for patient safety

By Sanjeev Sachdeva Safeguarding patient health is the foremost responsibility of the pharmaceutical sector. While …

Charity commits £800,000 to AI research into late breast cancer recurrence

Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …

Cori Clinical raises US$4m to expand AI platform for clinical trial design

Cori Clinical has raised US$4m in a seed funding round to expand its AI platform …

The Gateway to Local Adoption Series

Latest content